These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 30841919)

  • 41. Gene expression signatures of site-specificity in cancer metastases.
    Hartung F; Patil A; Meshram RJ; Weber GF
    Clin Exp Metastasis; 2020 Feb; 37(1):159-171. PubMed ID: 31555944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Promoter hypermethylation profiling of distant breast cancer metastases.
    Schrijver WA; Jiwa LS; van Diest PJ; Moelans CB
    Breast Cancer Res Treat; 2015 May; 151(1):41-55. PubMed ID: 25841351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization.
    So JY; Skrypek N; Yang HH; Merchant AS; Nelson GW; Chen WD; Ishii H; Chen JM; Hu G; Achyut BR; Yoon EC; Han L; Huang C; Cam MC; Zhao K; Lee MP; Yang L
    Cancer Res; 2020 Jun; 80(12):2612-2627. PubMed ID: 32265226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
    Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
    Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.
    España L; Martín B; Aragüés R; Chiva C; Oliva B; Andreu D; Sierra A
    Am J Pathol; 2005 Oct; 167(4):1125-37. PubMed ID: 16192647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
    Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
    Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative assessment of breast cancer liver metastasis expansion with patient-derived xenografts.
    Alzubi MA; Sohal SS; Sriram M; Turner TH; Zot P; Idowu M; Harrell JC
    Clin Exp Metastasis; 2019 Jun; 36(3):257-269. PubMed ID: 31069566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
    Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
    Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptomic analysis identifies organ-specific metastasis genes and pathways across different primary sites.
    Zhang L; Fan M; Napolitano F; Gao X; Xu Y; Li L
    J Transl Med; 2021 Jan; 19(1):31. PubMed ID: 33413400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
    Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
    Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells.
    Puig I; Chicote I; Tenbaum SP; Arqués O; Herance JR; Gispert JD; Jimenez J; Landolfi S; Caci K; Allende H; Mendizabal L; Moreno D; Charco R; Espín E; Prat A; Elez ME; Argilés G; Vivancos A; Tabernero J; Rojas S; Palmer HG
    Clin Cancer Res; 2013 Dec; 19(24):6787-801. PubMed ID: 24170545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
    Zuo Y; Ulu A; Chang JT; Frost JA
    Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain.
    Kijewska M; Viski C; Turrell F; Fitzpatrick A; van Weverwijk A; Gao Q; Iravani M; Isacke CM
    Breast Cancer Res; 2019 Jan; 21(1):4. PubMed ID: 30642388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth.
    Perurena N; Zandueta C; Martínez-Canarias S; Moreno H; Vicent S; Almeida AS; Guruceaga E; Gomis RR; Santisteban M; Egeblad M; Hermida J; Lecanda F
    J Hematol Oncol; 2017 Jan; 10(1):23. PubMed ID: 28103946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metastatic breast cancer cells are metabolically reprogrammed to maintain redox homeostasis during metastasis.
    Biondini M; Lehuédé C; Tabariès S; Annis MG; Pacis A; Ma EH; Tam C; Hsu BE; Audet-Delage Y; Abu-Thuraia A; Girondel C; Sabourin V; Totten SP; de Sá Tavares Russo M; Bridon G; Avizonis D; Guiot MC; St-Pierre J; Ursini-Siegel J; Jones R; Siegel PM
    Redox Biol; 2024 Sep; 75():103276. PubMed ID: 39053265
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Color-Coded Imaging of Breast Cancer Metastatic Niche Formation in Nude Mice.
    Suetsugu A; Momiyama M; Hiroshima Y; Shimizu M; Saji S; Moriwaki H; Bouvet M; Hoffman RM
    J Cell Biochem; 2015 Dec; 116(12):2730-4. PubMed ID: 25981355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer.
    Xu W; Zhao ZY; An QM; Dong B; Lv A; Li CP; Guan XY; Tian XY; Wu JH; Hao CY
    Int J Med Sci; 2020; 17(18):3073-3081. PubMed ID: 33173428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tropism between hepatic and pulmonary metastases in colorectal cancers.
    Kim SH; Choi SJ; Park JS; Lee J; Cho YB; Kang MW; Lee WY; Choi YS; Kim HK; Han J; Chun HK; Kim J
    Oncol Rep; 2012 Aug; 28(2):459-64. PubMed ID: 22664832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An Optimal Orthotopic Mouse Model for Human Colorectal Cancer Primary Tumor Growth and Spontaneous Metastasis.
    Hite N; Klinger A; Hellmers L; Maresh GA; Miller PE; Zhang X; Li L; Margolin DA
    Dis Colon Rectum; 2018 Jun; 61(6):698-705. PubMed ID: 29722728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.